Research location: “Many inventions, but not necessarily innovation” – Bayer manager calls for new deal for biotech
⚡ Quick Summary
According to Bayer board member Stefan Oelrich, Germany is endangering its innovative strength with low drug prices, too little venture capital - and inertia.
📰 Related Articles
Black and Red agree on income tax reform and growth package
Die Welt
Bayern star better than Messi?: England and Thomas Tuchel kneel in front of Harry Kane
n-tv
California introduces Bruce Lee Day: first Chinese-American with honorary day
Euronews DE
In Poland, fuel prices are exploding after the end of the price brake
Tagesschau
Harry Kane rages – Should the England star have received a penalty here?
Die Welt